CUTISS is a late-stage clinical TechBio company revolutionizing skin surgery with denovoSkin™, a first-in-class personalized tissue therapy for on-demand production of living human skin. This technology is designed for patients requiring skin surgery, from severe burns to reconstructive and aesthetic applications, offering a safe and effective alternative to the standard of care. CUTISS also leverages its scalable, automated production platform for advancements in regenerative medicine, space health research, and industrial bioengineered tissue applications.